These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 25246303)

  • 21. Unclassifiable arrhythmic cardiomyopathy associated with Emery-Dreifuss caused by a mutation in FHL1.
    San Román I; Navarro M; Martínez F; Albert L; Polo L; Guardiola J; García-Molina E; Muñoz-Esparza C; López-Ayala JM; Sabater-Molina M; Gimeno JR
    Clin Genet; 2016 Aug; 90(2):171-6. PubMed ID: 26857240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
    Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
    Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of FHL1 induces an age-dependent skeletal muscle myopathy associated with myofibrillar and intermyofibrillar disorganization in mice.
    Domenighetti AA; Chu PH; Wu T; Sheikh F; Gokhin DS; Guo LT; Cui Z; Peter AK; Christodoulou DC; Parfenov MG; Gorham JM; Li DY; Banerjee I; Lai X; Witzmann FA; Seidman CE; Seidman JG; Gomes AV; Shelton GD; Lieber RL; Chen J
    Hum Mol Genet; 2014 Jan; 23(1):209-25. PubMed ID: 23975679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).
    Shalaby S; Hayashi YK; Goto K; Ogawa M; Nonaka I; Noguchi S; Nishino I
    Neuromuscul Disord; 2008 Dec; 18(12):959-61. PubMed ID: 18952429
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiomyopathy and altered integrin-actin signaling in Fhl1 mutant female mice.
    Kubota A; Juanola-Falgarona M; Emmanuele V; Sanchez-Quintero MJ; Kariya S; Sera F; Homma S; Tanji K; Quinzii CM; Hirano M
    Hum Mol Genet; 2019 Jan; 28(2):209-219. PubMed ID: 30260394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Three novel FHL1 variants cause a mild phenotype of Emery-Dreifuss muscular dystrophy.
    Borch JDS; Krag T; Holm-Yildiz SD; Cetin H; Solheim TA; Fornander F; Straub V; Duno M; Vissing J
    Hum Mutat; 2022 Sep; 43(9):1234-1238. PubMed ID: 35607917
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
    Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
    Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.
    Willis TA; Wood CL; Hudson J; Polvikoski T; Barresi R; Lochmüller H; Bushby K; Straub V
    Clin Genet; 2016 Aug; 90(2):166-70. PubMed ID: 27409453
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of novel FHL1 mutations associated with X-linked scapuloperoneal myopathy in unrelated Chinese patients.
    Lin Y; Ban R; Qiao L; Chen J; Liu M; Liu J; Shi Q
    J Hum Genet; 2023 Jul; 68(7):477-484. PubMed ID: 36864287
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Electrocardiographic analysis in unclassifiable arrhythmic cardiomyopathy associated with Emery-Dreifuss caused by a mutation in FHL1.
    Peters S
    Int J Cardiol; 2016 Jul; 214():136. PubMed ID: 27061647
    [No Abstract]   [Full Text] [Related]  

  • 31. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
    Selcen D; Bromberg MB; Chin SS; Engel AG
    Neurology; 2011 Nov; 77(22):1951-9. PubMed ID: 22094483
    [TBL] [Abstract][Full Text] [Related]  

  • 32. X-linked dominant scapuloperoneal myopathy is due to a mutation in the gene encoding four-and-a-half-LIM protein 1.
    Quinzii CM; Vu TH; Min KC; Tanji K; Barral S; Grewal RP; Kattah A; Camaño P; Otaegui D; Kunimatsu T; Blake DM; Wilhelmsen KC; Rowland LP; Hays AP; Bonilla E; Hirano M
    Am J Hum Genet; 2008 Jan; 82(1):208-13. PubMed ID: 18179901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome Sequencing Identified a Splice Site Mutation in FHL1 that Causes Uruguay Syndrome, an X-Linked Disorder With Skeletal Muscle Hypertrophy and Premature Cardiac Death.
    Xue Y; Schoser B; Rao AR; Quadrelli R; Vaglio A; Rupp V; Beichler C; Nelson SF; Schapacher-Tilp G; Windpassinger C; Wilcox WR
    Circ Cardiovasc Genet; 2016 Apr; 9(2):130-5. PubMed ID: 26933038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FHL1-mutated reducing body myopathy.
    Lim KY; Kim HH; Sung JJ; Oh BM; Kim K; Park SH
    Neuropathology; 2020 Apr; 40(2):185-190. PubMed ID: 31803991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective muscle involvement in a family affected by a second LIM domain mutation of fhl1: an imaging study using computed tomography.
    Komagamine T; Kawai M; Kokubun N; Miyatake S; Ogata K; Hayashi YK; Nishino I; Hirata K
    J Neurol Sci; 2012 Jul; 318(1-2):163-7. PubMed ID: 22541254
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dysregulation of FHL1 spliceforms due to an indel mutation produces an Emery-Dreifuss muscular dystrophy plus phenotype.
    Tiffin HR; Jenkins ZA; Gray MJ; Cameron-Christie SR; Eaton J; Aftimos S; Markie D; Robertson SP
    Neurogenetics; 2013 May; 14(2):113-21. PubMed ID: 23456229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology.
    Pen AE; Nyegaard M; Fang M; Jiang H; Christensen R; Mølgaard H; Andersen H; Ulhøi BP; Østergaard JR; Væth S; Sommerlund M; de Brouwer AP; Zhang X; Jensen UB
    Eur J Med Genet; 2015 Apr; 58(4):222-9. PubMed ID: 25724586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Left ventricular hypertrophy caused by a novel nonsense mutation in FHL1.
    Gossios TD; Lopes LR; Elliott PM
    Eur J Med Genet; 2013 May; 56(5):251-5. PubMed ID: 23500067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical, histological and genetic characterization of reducing body myopathy caused by mutations in FHL1.
    Schessl J; Taratuto AL; Sewry C; Battini R; Chin SS; Maiti B; Dubrovsky AL; Erro MG; Espada G; Robertella M; Saccoliti M; Olmos P; Bridges LR; Standring P; Hu Y; Zou Y; Swoboda KJ; Scavina M; Goebel HH; Mitchell CA; Flanigan KM; Muntoni F; Bönnemann CG
    Brain; 2009 Feb; 132(Pt 2):452-64. PubMed ID: 19181672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
    Feldkirchner S; Walter MC; Müller S; Kubny C; Krause S; Kress W; Hanisch FG; Schoser B; Schessl J
    Neuromuscul Disord; 2013 May; 23(5):418-26. PubMed ID: 23489660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.